Loading...
Wallace Pharmaceuticals Private Limited — Famotidine Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #14 for Famotidine · $200.0K export value · DGFT Verified
Wallace Pharmaceuticals Private Limited is the #14 Indian exporter of Famotidine with $200.0K in export value and 4 verified shipments. Wallace Pharmaceuticals Private Limited holds a 0.4% market share in Famotidine exports across 1 countries. The company exports 4 pharmaceutical products worth $2.0M across 3 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $46.8M | 1,410 | 87.8% |
| SRI LANKA | $1.9M | 91 | 3.6% |
| JAPAN | $1.4M | 27 | 2.5% |
| CANADA | $719.2K | 69 | 1.3% |
| AUSTRALIA | $451.2K | 28 | 0.8% |
| EL SALVADOR | $326.5K | 19 | 0.6% |
| MYANMAR | $292.5K | 21 | 0.5% |
| OMAN | $237.6K | 17 | 0.4% |
| JORDAN | $208.9K | 7 | 0.4% |
| UNITED KINGDOM | $206.7K | 10 | 0.4% |
India exports Famotidine to 66 countries. The top destination is UNITED STATES (87.8%), followed by SRI LANKA and JAPAN.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MYLAN INSTITUTIONAL INC 2898 | UNITED STATES | $5.0M | 138 |
| J. KNIPPER & COMPANY | UNITED STATES | $3.2M | 77 |
| MYLAN INSTITUTIONAL INC | UNITED STATES | $2.6M | 72 |
| M S ASCEND LABORATORIES LLC | UNITED STATES | $1.3M | 25 |
| ASCEND LABORATORIES LLC | UNITED STATES |
India exported $40.4M worth of Famotidine through 2,750 shipments from 152 suppliers to 66 countries, serving 302 buyers globally. Wallace Pharmaceuticals Private Limited contributes $200.0K to this total, accounting for 0.4% of India's Famotidine exports.
Wallace Pharmaceuticals Private Limited's average Famotidine shipment value is $50.0K per consignment, based on 4 shipments totaling $200.0K.
Wallace Pharmaceuticals Private Limited ranks #14 among 152 Indian Famotidine exporters with a 0.4% market share. The top 3 exporters are VKT PHARMA PRIVATE LIMITED ($8.7M), ANNORA PHARMA PRIVATE LIMITED ($8.1M), MYLAN LABORATORIES LIMITED ($7.5M). Wallace Pharmaceuticals Private Limited processed 4 shipments to 1 destination countries.
What Wallace Pharmaceuticals Private Limited must comply with to export Famotidine to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | AUROBINDO PHARMA LIMITED | $400.0K | 8 | 1 | $50.0K |
| 15 | ZYDUS LIFESCIENCES LIMITED | $250.0K | 5 | 1 | $50.0K |
| 14 | WALLACE PHARMACEUTICALS PRIVATE LIMITED ★ | $200.0K | 4 | 1 | $50.0K |
Wallace Pharmaceuticals Private Limited ranks #14 among 152 Indian Famotidine exporters. Average shipment value of $50.0K compared to the market average of $265.7K. The closest competitors by value are AUROBINDO PHARMA LIMITED and ZYDUS LIFESCIENCES LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 264 | 9.6% |
| HYDERABAD ICD | 251 | 9.1% |
| SAHAR AIR | 239 | 8.7% |
| DELHI AIR | 188 | 6.8% |
| NHAVA SHEVA SEA (INNSA1) | 163 | 5.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 155 | 5.6% |
| HYDERABAD ICD (INSNF6) | 153 | 5.6% |
| HYDERABAD AIR | 86 | 3.1% |
Wallace Pharmaceuticals Private Limited also exports these gastrointestinal products. Each links to the detailed product page.
Wallace Pharmaceuticals Private Limited exports 4 products worth $2.0M. Beyond Famotidine, top products include Gliclazide, Sulfasalazine, Hydroxychloroquine. View the complete Wallace Pharmaceuticals Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Famotidine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Wallace Pharmaceuticals Private Limited's Famotidine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Wallace Pharmaceuticals Private Limited
Full Company Profile →
4 products · $2.0M total trade · 3 categories
| $977.7K |
| 22 |
| ASCEND LABORATORIES,LLC | UNITED STATES | $906.3K | 21 |
| GLENMARK THERAPEUTICS INC., USA | UNITED STATES | $900.0K | 18 |
| DR. REDDYS LABORATORIES, INC | UNITED STATES | $890.9K | 23 |
| TIME-CAP LABS, | UNITED STATES | $828.3K | 65 |
| XXROHXXLTHXXLC | UNITED STATES | $400.0K | 8 |
India's Famotidine is purchased by 302 buyers worldwide. The top buyer is MYLAN INSTITUTIONAL INC 2898 (UNITED STATES), followed by J. KNIPPER & COMPANY and MYLAN INSTITUTIONAL INC.
Generic Drug Application per Japan Pharmaceutical Affairs Act. Dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Timeline: 12–24 months
GMP & Export Requirements
Japanese GMP (J-GMP); PMDA on-site inspection of Indian manufacturing facility
Foreign Manufacturer Accreditation from PMDA; Japanese MAH (Marketing Authorization Holder) partner required
Note: Japan requires Yen-denominated NHI drug price listing. Stability data under ICH Zone IVb conditions.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 66+ countries, 302+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Wallace Pharmaceuticals Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Famotidine. For current shipment-level data, contact TransData Nexus.